Showing results (2261-2270 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 26, 2019
Prolonged response to 177Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumorAnne Ségolène Cottereau, Léopoldine Bricaire, Jennifer Arrondeau, et al.
Investigational New Drugs|October 26, 2019
Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cellsToshimi Hoshiko, Yasushi Kubota, Takuya Akisawa, et al.
Investigational New Drugs|October 26, 2019
Veliparib in ovarian cancer: a new synthetically lethal therapeutic approachStergios Boussios, Peeter Karihtala, Michele Moschetta, et al.
Investigational New Drugs|May 16, 2020
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatmentJean-Pierre Delord, Guillem Argilés, Jerôme Fayette, et al.
Investigational New Drugs|May 6, 2020
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cellsMałgorzata Opydo-Chanek, Iwona Cichoń, Agnieszka Rak, et al.
Investigational New Drugs|June 13, 2015
Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic propertiesAmna Ali, Timothy J Burns, Jacob D Lucrezi, et al.
Investigational New Drugs|July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
Investigational New Drugs|June 28, 2015
Cytotoxicity of anthraquinones from the roots of Pentas schimperi towards multi-factorial drug-resistant cancer cellsVictor Kuete, Arno R Nanfack Donfack, Armelle T Mbaveng, et al.
Investigational New Drugs|July 1, 2015
P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclibMark C de Gooijer, Ping Zhang, Nishita Thota, et al.
Investigational New Drugs|June 26, 2015
Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancerPhilippe Collery, Ahmed Mohsen, Anthony Kermagoret, et al.
Pageof 372